(Q35958060)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510390%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

Caspofungin for treatment of invasive aspergillosis in Germany: results of a pre-planned subanalysis of an international registry (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510390%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

0 references

0 references

invasive aspergillosis

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510390%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

6

Johan Maertens

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510390%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Gerlinde Egerer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510390%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Dietmar Reichert

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510390%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Peter Kaskel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510390%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Karl J Krobot

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510390%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

language of work or name

English

0 references

publication date

17 April 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510390%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Medical Research

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510390%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510390%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510390%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 2.0 Generic

29 January 2020

copyright license

1 reference

https://api.crossref.org/v1/works/10.1186/2047-783X-17-7

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/2047-783x-17-7

0 references

cites work

Caspofungin use in daily clinical practice for treatment of invasive aspergillosis: results of a prospective observational registry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3351716

Treatment of invasive fungal infections in cancer patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3351716

Patients at high risk of invasive fungal infections: when and how to treat

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3351716

Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3351716

Systemic Fungal Infections Caused by Aspergillus Species: Epidemiology, Infection Process and Virulence Determinants

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3351716

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3351716

Combinations of antifungal agents in therapy--what value are they?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3351716

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3351716

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3351716

European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update

2 October 2017

1 reference

https://api.crossref.org/works/10.1186%2F2047-783X-17-7

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2047-783X-17-7

Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2047-783X-17-7

An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2047-783X-17-7

Caspofungin as first line therapy of pulmonary invasive fungal infections in 32 immunocompromised patients with hematologic malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2047-783X-17-7

The hepatotoxicity of antifungal medications in bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2047-783X-17-7

Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies: a randomized pilot study (Combistrat trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F2047-783X-17-7

Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22510390

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/2047-783X-17-7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510390%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

29 January 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22510390%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference